Clinical Trial Update: Safety and Effectiveness of Corneal Crosslinking (CXL): Keratoconus and Post-Refractive Ectasia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating corneal crosslinking for keratoconus and post-refractive corneal ectasia, assessing safety and effectiveness; current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Keratoconus, Ectasia | Phase 3 | Status: UNKNOWN